Vitamin D as disease-modifying therapy for multiple sclerosis?
Expert Rev Clin Immunol
.
2021 Jul;17(7):691-693.
doi: 10.1080/1744666X.2021.1915772.
Epub 2021 Apr 15.
Authors
Matthew R Lincoln
1
2
,
Raphael Schneider
3
4
,
Jiwon Oh
3
4
Affiliations
1
Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
2
Broad Institute of Harvard and MIT, Cambridge, MA, USA.
3
Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
4
Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada.
PMID:
33836645
DOI:
10.1080/1744666X.2021.1915772
No abstract available
Keywords:
Multiple sclerosis; epidemiology; immunology; therapy; vitamin D.
Publication types
Editorial
MeSH terms
Humans
Multiple Sclerosis* / drug therapy
Vitamin D / therapeutic use
Vitamin D Deficiency*
Substances
Vitamin D